Literature DB >> 6304836

Clinical and serological response of sheep to serial challenge with different bluetongue virus types.

M H Jeggo, I D Gumm, W P Taylor.   

Abstract

A group of British sheep was infected with bluetongue virus 5 (BTV5) and subsequently challenged with the same virus type. Protection from this challenge and a homotypic BTV neutralising antibody response were observed. A second group of sheep was infected serially with three different BTV types. Animals previously exposed to BTV4 and BTV3 were found to be resistant to challenge by BTV6. Animals infected with BTV4 and challenged with BTV3 were shown to produce a transient heterotypic neutralising antibody response to a number of types. Although the level of this heterotypic response diminished with time, after challenge with BTV6 these animals developed a similar broad heterotypic response. The nature of this response and its implications in terms of observed protection merit consideration in future vaccine design and evaluation of field survey work.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304836

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  15 in total

1.  Purification, stability, and immunogenicity analyses of five bluetongue virus proteins for use in development of a subunit vaccine that allows differentiation of infected from vaccinated animals.

Authors:  Jenna Anderson; Emmanuel Bréard; Karin Lövgren Bengtsson; Kjell-Olov Grönvik; Stéphan Zientara; Jean-Francois Valarcher; Sara Hägglund
Journal:  Clin Vaccine Immunol       Date:  2014-01-22

2.  Cultivation of bluetongue virus-specific ovine T cells and their cross-reactivity with different serotype viruses.

Authors:  H Takamatsu; M H Jeggo
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

3.  Production and characterization of Monoclonal antibodies to bluetongue virus.

Authors:  Veerakyathappa Bhanuprakash; Madhusudhan Hosamani; Vinayagamurthy Balamurugan; Pradeep Narayan Gandhale; Gnanavel Venkatesan; Raj Kumar Singh
Journal:  Virol Sin       Date:  2011-02-18       Impact factor: 4.327

4.  Epidemiology of bluetongue and related orbiviruses in the Sultanate of Oman.

Authors:  S M al-Busaidy; P S Mellor
Journal:  Epidemiol Infect       Date:  1991-02       Impact factor: 2.451

5.  A study of the role of cell-mediated immunity in bluetongue virus infection in sheep, using cellular adoptive transfer techniques.

Authors:  M H Jeggo; R C Wardley; J Brownlie
Journal:  Immunology       Date:  1984-07       Impact factor: 7.397

6.  Full genome characterisation of bluetongue virus serotype 6 from the Netherlands 2008 and comparison to other field and vaccine strains.

Authors:  Sushila Maan; Narender S Maan; Piet A van Rijn; René G P van Gennip; Anna Sanders; Isabel M Wright; Carrie Batten; Bernd Hoffmann; Michael Eschbaumer; Chris A L Oura; Abraham C Potgieter; Kyriaki Nomikou; Peter P C Mertens
Journal:  PLoS One       Date:  2010-04-23       Impact factor: 3.240

7.  RT-PCR assays for seven serotypes of epizootic haemorrhagic disease virus & their use to type strains from the Mediterranean region and North America.

Authors:  Narender S Maan; Sushila Maan; Kyriaki Nomikou; Donna J Johnson; Mehdi El Harrak; Hafsa Madani; Hagai Yadin; Serife Incoglu; Kadir Yesilbag; Andrew B Allison; David E Stallknecht; Carrie Batten; Simon J Anthony; Peter P C Mertens
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

8.  Isolation of bluetongue and related viruses from Culicoides spp. in the Sudan.

Authors:  P S Mellor; R Osborne; D M Jennings
Journal:  J Hyg (Lond)       Date:  1984-12

9.  Bluetongue virus and epizootic haemorrhagic disease of deer virus serotypes in northern Colombian cattle.

Authors:  E J Homan; W P Taylor; H L de Ruiz; T M Yuill
Journal:  J Hyg (Lond)       Date:  1985-08

10.  Oncolytic bluetongue viruses: promise, progress, and perspectives.

Authors:  Joseph K-K Li
Journal:  Front Microbiol       Date:  2011-03-16       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.